These data were first presented by Nakul Ganju, MD, of Howard University Hospital, Washington, DC, at the 2026 Crohns and Colitis Congress on Friday, January 23, 2026, in Las Vegas, Nevada
Response times vary considerably based on injury severity, chronicity, individual healing capacity, and product quality
It is a measurable, documented effect that distinguishes cerebrolysin from virtually every other neuroprotective compound studied in clinical trials
The Timing Flexibility Window and When It Becomes Unsafe Can You Take Semaglutide a Day Early
Clinical trial design for alcoholic hepatitis
the 2024 Psychopharmacology e-cigarette cognition scoping review (impaired memory, concentration and decision-making in smokers and never-smokers)